Jia Litao, Hua Yujie, Zeng Jinshi, Liu Wenshuai, Wang Di, Zhou Guangdong, Liu Xia, Jiang Haiyue
Research Center of Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100144, PR China.
Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Key Laboratory of Tissue Engineering, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, PR China.
Bioact Mater. 2022 Mar 3;16:66-81. doi: 10.1016/j.bioactmat.2022.02.032. eCollection 2022 Oct.
Tissue engineering provides a promising strategy for auricular reconstruction. Although the first international clinical breakthrough of tissue-engineered auricular reconstruction has been realized based on polymer scaffolds, this approach has not been recognized as a clinically available treatment because of its unsatisfactory clinical efficacy. This is mainly since reconstruction constructs easily cause inflammation and deformation. In this study, we present a novel strategy for the development of biological auricle equivalents with precise shapes, low immunogenicity, and excellent mechanics using auricular chondrocytes and a bioactive bioink based on biomimetic microporous methacrylate-modified acellular cartilage matrix (ACMMA) with the assistance of gelatin methacrylate (GelMA), poly(ethylene oxide) (PEO), and polycaprolactone (PCL) by integrating multi-nozzle bioprinting technology. Photocrosslinkable ACMMA is used to emulate the intricacy of the cartilage-specific microenvironment for active cellular behavior, while GelMA, PEO, and PCL are used to balance printability and physical properties for precise structural stability, form the microporous structure for unhindered nutrient exchange, and provide mechanical support for higher shape fidelity, respectively. Finally, mature auricular cartilage-like tissues with high morphological fidelity, excellent elasticity, abundant cartilage lacunae, and cartilage-specific ECM deposition are successfully regenerated , which provides new opportunities and novel strategies for the fabrication and regeneration of patient-specific auricular cartilage.
组织工程为耳廓重建提供了一种很有前景的策略。尽管基于聚合物支架已实现了组织工程耳廓重建的首个国际临床突破,但由于其临床疗效不尽人意,这种方法尚未被视为一种临床可用的治疗方法。这主要是因为重建结构容易引起炎症和变形。在本研究中,我们提出了一种新策略,通过整合多喷嘴生物打印技术,利用耳廓软骨细胞和基于仿生微孔甲基丙烯酸酯修饰的脱细胞软骨基质(ACMMA)的生物活性生物墨水,并借助甲基丙烯酸明胶(GelMA)、聚环氧乙烷(PEO)和聚己内酯(PCL),来开发具有精确形状、低免疫原性和优异力学性能的生物耳廓等效物。可光交联的ACMMA用于模拟软骨特异性微环境的复杂性以实现活跃的细胞行为,而GelMA、PEO和PCL分别用于平衡可打印性和物理性能以实现精确的结构稳定性、形成微孔结构以实现不受阻碍的营养交换以及提供机械支撑以实现更高的形状保真度。最终,成功再生出了具有高形态保真度、优异弹性、丰富软骨陷窝和软骨特异性细胞外基质沉积的成熟耳廓软骨样组织,这为患者特异性耳廓软骨的制造和再生提供了新的机遇和新颖策略。